Purnell Choppin, a physician, virologist, and scientific administrator who performed pioneering research on viruses at The Rockefeller University and later exerted a powerful influence on biomedical research as president of the Howard Hughes Medical Institute, has died at the age of 91.
For Rockefeller’s class of 2021, it has been a year with both challenges and accomplishments.
According to this year’s CWTS Leiden Ranking of over 1200 universities from 69 countries, Rockefeller has the highest proportion of frequently cited scientific publications.
Redesigning the exhibit provided an opportunity to consider how to best honor and commemorate Rockefeller award winners. Discussions with university leadership and an ad-hoc faculty committee steered the process and led to a broadening of the criteria for inclusion.
The author of The Evolution of Beauty was presented with Rockefeller’s science writing award, which honors scientists as inspirational authors.
The joint program between Weill Cornell Medicine, The Rockefeller University, and Memorial Sloan Kettering Cancer Center will be lead by Hsu, an accomplished physician-scientist who specializes in immunology research and treatment of blood cancers.
Cohen, a physician-scientist exploring obesity and metabolic disease, has conducted groundbreaking research on the complex inner workings of fat tissue.
A pioneer in the field of mucosal immunology, Mucida is unlocking the secrets of the digestive system and answering fundamental questions about the origins of human disease.
Kreek conducted landmark studies that led to the establishment of methadone as a treatment for heroin addiction. Her work not only yielded new treatments for addiction disorders, but also influenced societal attitudes toward them. She was 84.
The university has named its next vice president and chief investment officer. Volent, who for decades oversaw investments at Bowdoin College, will assume stewardship of Rockefeller's endowment in August.